QuaDPharma is Pharmaceuticals in United States that focus on stability program management business. Founded in 2010. They cover business area such as manufacturer, tester, small-batch pharmaceutical, facility, customer service, small-scale manufacturing, process development, raw material, finished good analytical testing, product stability program management, pharmaceutical Industries.
2010
( 14 years old in 2024 )
Stability Program Management
-
11342 Main Street
Clarence, NY 14031
United States
Private
manufacturertestersmall-batch pharmaceuticalfacilitycustomer servicesmall-scale manufacturingprocess developmentraw materialfinished good analytical testingproduct stability program managementpharmaceutical Industries
* We use standard office opening hours in near QuaDPharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
QuaDPharma is Pharmaceuticals business from United States that founded in 2010 (14 years old in 2024), QuaDPharma business is focusing on Stability Program Management.
QuaDPharma headquarter office and corporate office address is located in 11342 Main Street Clarence, NY 14031 United States.
QuaDPharma was founded in United States.
In 2024, QuaDPharma is currently focus on stability program management sector.
Above is snippet of Google Trends for "stability program management" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with QuaDPharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
